Skip to content
Oncosil Medical
Main menu
  • Logo on scroll
  • Home
  • About
    • Company History
    • Leadership Team
    • Our Board
  • Research & Technology
    • Overview
    • Chemotherapy & OncoSil™
    • Indications
    • OncoSil™ Implant
    • Implant Aftercare
    • Radiation Safety Aspects
    • About Clinical Trials
    • Clinical Studies
    • Becoming an OncoSil™ Trial Centre
    • Important Risk Information
    • FAQ
  • Investor Centre
    • Overview
    • ASX Announcements
    • Analyst Reports
    • Annual Reports
    • Events & Presentations
    • Subscribe to Updates
    • Corporate Governance
  • Media Coverage
  • Contact Us

Medical Investment Opportunities -
Cancer Research: Overview

Welcome to the OncoSil Medical Ltd Investor Centre.

OncoSil Medical Ltd is a publicly traded biotechnology company listed on the Australian stock exchange (ASX: OSL). OncoSil is focused on delivering innovative interventional oncology therapies for patients with pancreatic cancer and liver cancer.

Get in touch

OncoSil Medical Ltd,
Suite 402, Level 4 50 Berry Street,
North Sydney, NSW 2060
+61 2 9223 3344
info@oncosil.com.au
Follow us on Twitter
Follow us on LinkedIn
Footer
  • Disclaimer
  • Copyright ©2019 Oncosil Medical Ltd
  • Designed & Powered by Web Force 5